文献速递角膜与眼表疾病

跨上皮快速角膜胶原交联术治疗薄角膜进展性圆锥角膜的一年结果

[Accelerated transepithelial corneal collagen cross-linking for progressive keratoconus with a thin cornea: one-year results].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2017-01-01

前瞻性非随机临床研究纳入19例(19只眼)最薄角膜厚度380~420 μm的进展性圆锥角膜患者,行跨上皮快速角膜胶原交联术(A-TE-CXL)。术后12个月K(MAX)与K2较术前显著下降,角膜内皮细胞密度保持稳定,未见角膜感染、瘢痕、溃疡等并发症。

要点

  • 术后12个月K(MAX)为(55.67±4.91)D,较术前(57.35±5.54)D显著下降(t=3.044,P<0.01)。
  • 术后12个月K2为(52.18±3.70)D,较术前(52.70±3.56)D显著下降(t=2.384,P<0.05)。
  • 术前及术后12个月角膜内皮细胞密度差异无统计学意义(t=0.692,P>0.05)。

核心结论

  • 术后1年内,A-TE-CXL治疗薄角膜进展性圆锥角膜有效且安全。
  • A-TE-CXL具有手术时间很短、恢复迅速、并发症极少的优点,有潜力成为圆锥角膜治疗的有效替代方案。

研究设计与样本

  • 前瞻性非随机临床研究,纳入2015年1至2月间在厦门大学附属厦门眼科中心确诊的进展期圆锥角膜患者19例(19只眼)。
  • 纳入标准为最薄角膜厚度(含上皮)380~420 μm,使用KXL快速交联系统行A-TE-CXL术。
  • 术前及术后1周内、1、3、6及12个月评估疼痛及异物感评分、裂隙灯检查、裸眼与矫正视力、角膜地形图、前节OCT、角膜共聚焦显微镜及角膜内皮细胞计数,采用配对t检验统计分析。

主要发现

  • 术后1天内多数患者有轻度刺痛和中度异物感,术后第2天基本消失;术后24小时存在少量角膜上皮缺损,术后第2天恢复至术前水平。
  • 术后1个月角膜最薄点厚度为(378.9±17.1)μm,较术前(395.2±13.8)μm降低(t=2.982,P<0.01)。
  • 术后12个月K(MAX)为(55.67±4.91)D,较术前(57.35±5.54)D下降(t=3.044,P<0.01);K2为(52.18±3.70)D,较术前(52.70±3.56)D下降(t=2.384,P<0.05)。
  • 术后1个月内前节OCT可见浅层基质密度增高及前后基质间「分界线」;共聚焦显微镜可见浅层基质纤维显著增粗、纤维间连接增加,深度90~120 μm。
  • 术前及术后12个月角膜内皮细胞密度差异无统计学意义(t=0.692,P>0.05);所有患者未见角膜感染、瘢痕、角膜溃疡、持续性上皮缺损等并发症。

关键数值与推荐

  • 最薄角膜厚度(含上皮)380~420 μm为纳入标准。
  • 术后1个月角膜最薄点厚度(378.9±17.1)μm vs 术前(395.2±13.8)μm(t=2.982,P<0.01)。
  • 术后12个月K(MAX)(55.67±4.91)D vs 术前(57.35±5.54)D(t=3.044,P<0.01)。
  • 术后12个月K2(52.18±3.70)D vs 术前(52.70±3.56)D(t=2.384,P<0.05)。
  • 角膜内皮细胞密度术前与术后12个月差异无统计学意义(t=0.692,P>0.05)。

临床怎么用

  • 作者认为A-TE-CXL术后1年内对薄角膜进展性圆锥角膜的管理有效且安全。
  • 作者认为A-TE-CXL具有手术时间很短、恢复迅速、并发症极少的优点,有潜力成为圆锥角膜治疗的有效替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the clinical results of keratoconic eyes with a thin cornea treated with accelerated transepithelial corneal collagen cross-linking (A-TE-CXL) within 1 year. Methods: Nineteen eyes of 19 patients with progressive keratoconus with a minimum corneal thickness from 380 μm to 420 μm (including the epithelium) were included in this prospective, nonrandomized clinical study and treated with A-TE-CXL. Scoring of pain and foreign body sensation, slit lamp examination, uncorrected visual acuity, best corrected distance visual acuity, corneal topography, anterior segment optical coherence tomography, in vivo corneal confocal microscopy and endothelial cell count were assessed before surgery and at 1, 3, 6 and 12 months postoperatively. Paired t test was applied for statistical analysis. Results: Mild pain and moderate foreign body sensation were reported by most patients within postoperative 24 hours, but rapidly disappeared on day 2. Extremely mild epithelial damage was observed within postoperative 24 hours, and the epithelium fully recovered on day 2. Improvement of visual acuity was recorded at 3 and 12 months. Pentacam corneal topography revealed a significant reduction of the thickness of the thinnest location from(395.2±13.8)μm preoperatively to (378.9±17.1)μm at 1 month postoperatively (t=2.982, P<0.01). Front curvature values were reduced postoperatively. K(MAX) was significantly decreased at 12 months (55.67±4.91) compared with (57.35±5.54) preoperatively, while K2 was also significantly decreased at 12 months (52.18±3.70) compared with (52.70±3.56) preoperatively (K(MAX), t=3.044, P<0.01. K2, t=2.384, P<0.05) . Within 1 month postoperatively, optical coherence tomography exhibited an increase of reflectance with a demarcation line in the anterior stroma. In vivo confocal microscopy also showed significant thickening and increased connections of collagen fibers with a maximal depth at about 90 to 120 μm. The corneal endothelial cell density remained stable (t=0.692, P>0.05). None of the patients showed postoperative complications such as corneal infection, scarring and ulceration. Conclusions: Within 1 year postoperatively, A-TE-CXL was effective and safe for the management of progressive keratoconus with a thin cornea. A-TE-CXL showed the advantages of very short time consuming in surgery, rapid recovery and very few complications, and had the potential to become a valid alternative for the treatment of keratoconus. (Chin J Ophthalmol, 2017, 53: 694-700). 目的: 探讨使用跨上皮快速角膜胶原交联术(A-TE-CXL)治疗较薄型圆锥角膜的早期临床效果。 方法: 前瞻性非随机临床研究。收集2015年1至2月间在厦门大学附属厦门眼科中心确诊为进展期圆锥角膜且符合最薄角膜厚度(含上皮)为380~420 μm的19例患者(19只眼),予使用KXL快速交联系统进行A-TE-CXL术。在术前和术后1周内,术后1、3、6及12个月时分别进行疼痛及异物感评分、裂隙灯检查、裸眼与矫正视力、角膜地形图、前节光学相干层析成像术(OCT)、角膜共聚焦显微镜及角膜内皮细胞计数检查,记录并使用配对t检验进行统计分析。 结果: 患者接受A-TE-CXL术后1 d内存在轻度刺痛和中度异物感,术后1 d时基本消失。术后24 h存在少量角膜上皮缺损,术后2 d时恢复至术前水平。部分患者裸眼视力提高,部分患者最佳矫正视力提高。术后1个月时角膜最薄点厚度为(378.9±17.1)μm,较术前(395.2±13.8)μm降低(t=2.982,P<0.01)。术后角膜前表面曲率参数均低于术前值,其中术后12个月K(MAX)值为(55.67±4.91)D,术前为(57.35±5.54)D;术后12个月K2值为(52.18±3.70)D,术前为(52.70±3.56)D,差异均具有统计学意义(K(MAX):t=3.044,P<0.01;K2:t=2.384,P<0.05)。术后1个月内,前节OCT可见浅层基质密度增高,前后基质间存在"分界线";共聚焦显微镜下可见浅层基质内纤维显著增粗,纤维间连接增加,深度90~120 μm。术前及术后12个月角膜内皮细胞密度差异无统计学意义(t=0.692,P>0.05)。所有患者未见角膜感染、瘢痕、角膜溃疡、持续性上皮缺损等并发症。 结论: A-TE-CXL治疗较薄型进展期圆锥角膜早期效果良好,其手术时间短,恢复迅速,尚未见不良反应,是一种良好的角膜交联方案。(中华眼科杂志,2017,53:694-700).

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Lin ZR, Wu HP, Luo SR, et al. [Accelerated transepithelial corneal collagen cross-linking for progressive keratoconus with a thin cornea: one-year results]. Zhonghua Yan Ke Za Zhi. 2017. PMID: 28926888. doi:10.3760/cma.j.issn.0412-4081.2017.09.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。